Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (431-440 of 626) with videos related to

Pageof 63
Sort By:
Medical Care Research and Review : MCRR|February 27, 2009
Relationship of hospital organizational culture to patient safety climate in the Veterans Health AdministrationChristine W Hartmann, Mark Meterko, Amy K Rosen, et al.
Bioorganic & Medicinal Chemistry|January 20, 2016
Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitorsSaurabh Aggarwal, Manoj Kumar Mahapatra, Rajnish Kumar, et al.
European Journal of Medicinal Chemistry|June 30, 2014
Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activitiesEnrico Perspicace, Liliana Cozzoli, Emanuele M Gargano, et al.
Journal of Medicinal Chemistry|December 30, 2010
New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseasesSandrine Marchais-Oberwinkler, Marie Wetzel, Erika Ziegler, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 5, 2012
Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitroÁgnes Berényi, Martin Frotscher, Sandrine Marchais-Oberwinkler, et al.
Archiv Der Pharmazie|May 31, 2001
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic propertiesS Schertl, R W Hartmann, C Batzl-Hartmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 22, 2020
Crystalline Sponges as a Sensitive and Fast Method for Metabolite Identification: Application to Gemfibrozil and its Phase I and II MetabolitesLara Rosenberger, Carolina von Essen, Anupam Khutia, et al.
BMC Biotechnology|February 2, 2011
Expression, secretion and surface display of a human alkaline phosphatase by the ciliate Tetrahymena thermophilaIngo Aldag, Ulrike Bockau, Jan Rossdorf, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitorsMarc Le Borgne, Pascal Marchand, Marie-Renee Nourrisson, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 18, 2006
Three-dimensional model of cytochrome P450 human aromataseCedric Loge, Marc Le Borgne, Pascal Marchand, et al.
Pageof 63

Showing results (431-440 of 626) with videos related to

Sort By:
Pageof 63
Medical Care Research and Review : MCRR|February 27, 2009
Relationship of hospital organizational culture to patient safety climate in the Veterans Health AdministrationChristine W Hartmann, Mark Meterko, Amy K Rosen, et al.
Bioorganic & Medicinal Chemistry|January 20, 2016
Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitorsSaurabh Aggarwal, Manoj Kumar Mahapatra, Rajnish Kumar, et al.
European Journal of Medicinal Chemistry|June 30, 2014
Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activitiesEnrico Perspicace, Liliana Cozzoli, Emanuele M Gargano, et al.
Journal of Medicinal Chemistry|December 30, 2010
New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseasesSandrine Marchais-Oberwinkler, Marie Wetzel, Erika Ziegler, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 5, 2012
Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitroÁgnes Berényi, Martin Frotscher, Sandrine Marchais-Oberwinkler, et al.
Archiv Der Pharmazie|May 31, 2001
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic propertiesS Schertl, R W Hartmann, C Batzl-Hartmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 22, 2020
Crystalline Sponges as a Sensitive and Fast Method for Metabolite Identification: Application to Gemfibrozil and its Phase I and II MetabolitesLara Rosenberger, Carolina von Essen, Anupam Khutia, et al.
BMC Biotechnology|February 2, 2011
Expression, secretion and surface display of a human alkaline phosphatase by the ciliate Tetrahymena thermophilaIngo Aldag, Ulrike Bockau, Jan Rossdorf, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitorsMarc Le Borgne, Pascal Marchand, Marie-Renee Nourrisson, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 18, 2006
Three-dimensional model of cytochrome P450 human aromataseCedric Loge, Marc Le Borgne, Pascal Marchand, et al.
Pageof 63